Literature DB >> 27706805

Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer.

S Pucciarelli1, F Giandomenico1, A De Paoli2, T Gavaruzzi3, L Lotto3,4, G Mantello5, C Barba6, P Zotti7, S Flora2,7, P Del Bianco8.   

Abstract

BACKGROUND: Local excision for rectal cancer is expected to offer a better functional outcome than conventional surgery. The aim of the present study was to compare quality of life and bowel function in patients with rectal cancer who underwent either local excision or conventional surgery after chemoradiotherapy.
METHODS: This was a retrospective multicentre study. Patients who underwent local excision were compared with those who had mesorectal excision. Quality of life and bowel function were investigated using validated questionnaires (European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, EORTC QLQ-CR29 and Memorial Sloan-Kettering Cancer Center Bowel Function Instrument) at a median follow-up of 49 (range 13-95) months. Further analysis was undertaken of data from patients who underwent local excision alone compared with those requiring subsequent radical surgery. Statistical significance was set at P < 0·010.
RESULTS: The mean constipation score was significantly better in the local excision group than in the mesorectal excision group (3·8 (95 per cent c.i. 0·3 to 7·2) versus 19·8 (12·1 to 27·4); P < 0·001). Compared with patients who underwent mesorectal excision, those who had local excision had less sensation of incomplete emptying (mean score 3·7 (3·4 to 4·0) versus 2·8 (2·5 to 3·1); P < 0·001) and second bowel movements within 15 min (mean score 3·6 (3·3 to 3·9) versus 3·0 (2·7 to 3·3); P = 0·006). Patients who underwent local excision alone scored better than those who had mesorectal excision, particularly for bowel function, who, in turn, scored better than patients requiring subsequent radical surgery following local excision.
CONCLUSION: Patients who underwent local excision had a better quality of life and bowel function than those who underwent mesorectal excision.
© 2016 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27706805     DOI: 10.1002/bjs.10318

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study.

Authors:  A Barina; A De Paoli; P Delrio; M Guerrieri; A Muratore; F Bianco; D Vespa; C Asteria; E Morpurgo; A Restivo; C Coco; U Pace; C Belluco; C Aschele; S Lonardi; V Valentini; G Mantello; I Maretto; P Del Bianco; A Perin; S Pucciarelli
Journal:  Tech Coloproctol       Date:  2017-07-28       Impact factor: 3.781

2.  Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis.

Authors:  Lawrence Lee; Justin Kelly; George J Nassif; Sam B Atallah; Matthew R Albert; Ravi Shridhar; John R T Monson
Journal:  J Gastrointest Surg       Date:  2017-08-17       Impact factor: 3.452

3.  Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.

Authors:  Francesco Marchegiani; Valeria Palatucci; Giulia Capelli; Mario Guerrieri; Claudio Belluco; Daniela Rega; Emilio Morpurgo; Claudio Coco; Angelo Restivo; Silvia De Franciscis; Carlo Aschele; Alessandro Perin; Michele Bonomo; Andrea Muratore; Antonino Spinelli; Salvatore Ramuscello; Francesca Bergamo; Giampaolo Montesi; Gaya Spolverato; Paola Del Bianco; Maria Antonietta Gambacorta; Paolo Delrio; Salvatore Pucciarelli
Journal:  Ann Surg Oncol       Date:  2021-12-02       Impact factor: 5.344

4.  ASO Author Reflections: Rectal Preservation After Major or Complete Clinical Response to Neoadjuvant Therapy-The Safety of Integrated Approaches.

Authors:  Francesco Marchegiani; Gaya Spolverato; Salvatore Pucciarelli
Journal:  Ann Surg Oncol       Date:  2021-12-02       Impact factor: 5.344

5.  Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study.

Authors:  Roberto Peltrini; Simone Castiglioni; Nicola Imperatore; Monica Ortenzi; Daniela Rega; Valentina Romeo; Valerio Caracino; Edoardo Liberatore; Massimo Basti; Emanuele Santoro; Umberto Bracale; Paolo Delrio; Felice Mucilli; Mario Guerrieri; Francesco Corcione
Journal:  Tech Coloproctol       Date:  2022-10-14       Impact factor: 3.699

6.  Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Akira Tanaka; Kazutake Okada; Gota Saito; Hiroshi Miyakita; Takeshi Akiba; Hiroshi Yamamuro
Journal:  Oncology       Date:  2018-06-15       Impact factor: 2.935

7.  The effect of demographic, clinical, and pathological data on quality of life in rectum cancer.

Authors:  Yasemin Benderli Cihan; Ahmet Ozturk
Journal:  Support Care Cancer       Date:  2021-06-02       Impact factor: 3.603

Review 8.  Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project.

Authors:  Mauro Podda; Patricia Sylla; Gianluca Baiocchi; Michel Adamina; Vanni Agnoletti; Ferdinando Agresta; Luca Ansaloni; Alberto Arezzo; Nicola Avenia; Walter Biffl; Antonio Biondi; Simona Bui; Fabio C Campanile; Paolo Carcoforo; Claudia Commisso; Antonio Crucitti; Nicola De'Angelis; Gian Luigi De'Angelis; Massimo De Filippo; Belinda De Simone; Salomone Di Saverio; Giorgio Ercolani; Gustavo P Fraga; Francesco Gabrielli; Federica Gaiani; Mario Guerrieri; Angelo Guttadauro; Yoram Kluger; Ari K Leppaniemi; Andrea Loffredo; Tiziana Meschi; Ernest E Moore; Monica Ortenzi; Francesco Pata; Dario Parini; Adolfo Pisanu; Gilberto Poggioli; Andrea Polistena; Alessandro Puzziello; Fabio Rondelli; Massimo Sartelli; Neil Smart; Michael E Sugrue; Patricia Tejedor; Marco Vacante; Federico Coccolini; Justin Davies; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-07-02       Impact factor: 5.469

9.  Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.

Authors:  Rutger C H Stijns; Eelco J R de Graaf; Cornelis J A Punt; Iris D Nagtegaal; Joost J M E Nuyttens; Esther van Meerten; Pieter J Tanis; Ignace H J T de Hingh; George P van der Schelling; Yair Acherman; Jeroen W A Leijtens; Andreas J A Bremers; Geerard L Beets; Christiaan Hoff; Cornelis Verhoef; Corrie A M Marijnen; Johannes H W de Wilt
Journal:  JAMA Surg       Date:  2019-01-01       Impact factor: 14.766

10.  Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.

Authors:  Takeshi Sasaki; Yoshinori Ito; Masayuki Ohue; Yukihide Kanemitsu; Takaya Kobatake; Masaaki Ito; Yoshihiro Moriya; Norio Saito
Journal:  Dis Colon Rectum       Date:  2017-09       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.